Lord Moynihan of Chelsea

Lord Moynihan of Chelsea's full title is The Lord Moynihan of Chelsea OBE. His name is Jonathan Patrick Moynihan, and he is a current member of the House of Lords.

Registered Interests

Registered Interests for Lord Moynihan of Chelsea.

The Register is updated continuously throughout each sitting day and at regular intervals on other days.

Category 3: Person with significant control of a company (PSC)

  • JoCR Productions Limited (artistic and related productions)
  • Moynitrust (incorporated arm of charity)
  • Parents and Teachers for Excellence
  • Plaquetec Limited (research and commercial development concerning coronary heart disease)
  • Vos Amis Limited (investment advice, personal services and real estate)

Category 4: Shareholdings (a)

  • JoCR Productions Limited (artistic and related productions)
  • Vos Amis Limited (investment advice, personal services and real estate)

Category 4: Shareholdings (b)

  • Plaquetec Limited (research and commercial development concerning coronary heart disease)
  • Asset Match (private market trading platform)
  • Brewdog (brewing)
  • Libero Pharma (research and commercial development in opioid receptor antagonism)
  • Map of Agriculture (global data platform connecting farms and industry)
  • Ptarmigan Planning Ltd (strategic land planning)
  • WebTel Mobi (specialised network provider)
  • Shelley Media (Ingenious Broadcasting) (investment company for independent film and television programmes)
  • Deepbridge Life Sciences (investment in healthcare innovation companies)
  • FibaTech Industries (production of fibre-reinforced polymers)
  • Well Safe Solutions (oil well decommissioning)
  • Money Hub (financial services app)
  • Sonorous NV (research and commercial development in symptomatic cerebral venous diseases)
  • Itemize Corp (financial transaction processing)
  • Terrestrial Energy (molten salt and fission technology)
  • HzO (nanocoating solutions for electronics)
  • Candel Therapeutics (research and development in viral immunotherapies)
  • Journey Medical Corp (research and development in skin care)
  • Evotec (research and development in effective therapeutics)
  • Fortress Biotech (research and development in biopharmaceuticals)
  • Mustang Bio (research and development in next generation therapies)
  • TG Therapeutics (research and development in B-cell biologies)
  • Astra Zeneca (pharmaceuticals)
  • BP (oil)
  • Nestle (food and beverages)
  • Ocado (food delivery)
  • Shell (oil)
  • Schlumberger (global technology)
  • Total Energies (oil)
  • Sabby Volatility Fund (hedge fund)
  • CQS Credit Multi Asset Fund (research-driven credit strategies hedge fund)
  • East Rocky LLP (hedge fund)
  • Cerus Endovascular (sold to Stryker in May 2023) (research and development in interventional neuroradiology devices)
  • Guinness Ventures (investment in early-stage businesses)
  • Adaptimmune (cell therapy for cancer)
  • Avenue Therapeutics (research and development in neurological diseases)
  • Apax Global Alpha Limited (private equity investment trust)
  • Neuberger Berman (private equity investment trust)
  • HG Capital Trust (private equity investment trust)
  • HarbourVest (private equity investment trust)

Category 6: Sponsorship

  • The member receives administrative support for his parliamentary work from two employees of Vos Amis Limited (see categories 3, 4(a) and 10(a))

Category 10: Non-financial interests (a)

  • Director, JoCR Productions Limited (artistic and related productions)
  • Director, Vos Amis Limited (investment advice, personal services and real estate)

Category 10: Non-financial interests (b)

  • Foundation Fellow, Balliol College, Oxford

Category 10: Non-financial interests (d)

  • Member, Advisory Board, Free Speech Union
  • Member, Advisory Board, Independent Business Advisory Network

Category 10: Non-financial interests (e)

  • Chairman and trustee, The Injustice Foundation
  • Chairman and trustee, Moynitrust, and director of the associated company
  • Chairman and director, Parents and Teachers for Excellence